Adam Marcus

Do some IQ data need a ‘public health warning?’ A paper based on a controversial psychologist’s data is retracted

A journal has retracted a controversial 2010 article on intelligence and infections that was based on data gathered decades ago by a now-deceased researcher who lost his emeritus status in 2018 after students said his work was racist and sexist.

The article, “Parasite prevalence and the worldwide distribution of cognitive ability’, was published in Proceedings of the Royal Society B, by a group at the University of New Mexico. Their claim, according to the abstract:

The worldwide distribution of cognitive ability is determined in part by variation in the intensity of infectious diseases. From an energetics standpoint, a developing human will have difficulty building a brain and fighting off infectious diseases at the same time, as both are very metabolically costly tasks.

Overlaying average national IQ with parasitic stress, they found “robust worldwide” correlations in five of six regions of the globe:

Cancer paper earns expression of concern nearly two years after investigation report is revealed

A Springer Nature journal has issued an expression of concern for a 16-year-old paper by Carlo Croce, the cancer researcher – and noted art collector – at The Ohio State University three years after the publication had received a correction for problematic images and roughly 20 months after the news division at Nature reported on a pair of institutional investigations into problems with Croce’s work.

As we and others have reported, those investigations concluded Croce had not committed misconduct but had overlooked the misdeeds of others in his lab.

Here’s the notice for the paper, “MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer,” which Oncogene published in 2008:

Medical society takes millions from company that sued it for defamation – and lost

When the American Society of Anesthesiologists last October announced the receipt of a $2.5 million donation from a drug company – “to advance education and innovation for our members” – the news could have been dismissed with a shrug. After all, such gifts from industry to medical societies are commonplace.

What makes this case noteworthy is that until the donation, the ASA and the drug maker, Pacira BioSciences, were better known as adversaries embroiled in a bitter lawsuit over three articles about the company’s flagship product the society had published in 2021 in its main scientific journal.

The papers, which questioned the effectiveness of Exparel, an anesthetic intended for the treatment of patients undergoing orthopedic surgery and other procedures. As we reported in May 2021, as part of a larger suit against the ASA, Pacira demanded in legal filings that the ASA and its journal, Anesthesiology, retract the papers, which it considered libelous.

The company didn’t hold that stance long, however. We wrote then:

Paper claiming ‘extensive’ harms of COVID-19 vaccines to be retracted

A journal is retracting a paper on the purported harms of vaccines against COVID-19 written in part by authors who have had similar work retracted before.

The article, “COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign,” appeared late last month in Cureus, which used to be a stand-alone journal but is now owned by Springer Nature. (It has appeared frequently in these pages.)

Graham Parker, Director of Publishing and Customer Success at Cureus, told Retraction Watch:

I can confirm we will be retracting it by the end of the week, as we have provided the authors with a deadline to reply and indicate whether they agree or disagree with the retraction.

The senior author on the work was Peter McCullough, a cardiologist at the Institute of Pure and Applied Knowledge who lost his board certification after the American Board of Internal Medicine found he had “provided false or inaccurate medical information to the public.”

Springer Nature journal pulls nearly three dozen papers from special issues

A Springer Nature journal retracted 34 papers earlier this month, including, ironically enough, one on how to detect fake news, which appeared in special guest-edited issues hacked by publication cheats.

Special issues have emerged over the past few years as particularly vulnerable to paper mills. Last March, we reported that Wiley was taking a $9 million write-down after its Hindawi subsidiary paused publication of such issues because they were badly hacked by paper mills.

“Hybrid deep learning model for automatic fake news detection,” from a group in Turkey led by Othman A. Hanshal, was published last February in Applied Nanoscience. The retraction notice reads:

‘Nonsensical content’: Springer Nature journal breaks up with a paper on a love story

You can love math, but can you math love?

Scientific Reports has retracted a 2023 paper that tried to do just that by imposing a numerical model onto an ancient Persian love story that may have influenced Shakespeare’s Romeo and Juliet.

The paper, “A fractional order nonlinear model of the love story of Layla and Majnun,” was written by Zulqurnain Sabir and Salem Ben Said, both mathematicians at United Arab Emirates University. The article has been cited three times, according to Clarivate Analytics’ Web of Science.

According to the abstract:

Publisher error claims joke paper, April Fools’ tradition – three years later

A journal says a content management mishap led to the publication, and subsequent retraction, of a gag essay not intended for wide distribution.

Why the retraction happened three and a half years after the paper’s publication remains murky.

This story belongs to the early days of the COVID-19 pandemic, back when Proteins: Structure, Function, and Bioinformatics, a Wiley title, used to gather spoof papers for its annual April Fools edition.

As Kristofer Barr, an assistant research integrity auditor at Wiley, told us:

Copy and euphemize: When ‘an honor mistake’ means plagiarism

Readers who have been with us for the long haul may remember we used to collect a catalog of our favorite euphemisms for plagiarism. That list died with the demise of Lab Times, for which we used to write a regular column (although we did write this piece a bit later) – but the magazine’s passing did not mark the end of journals that speak with mealy mouths.

The latest such euphemism to catch our eye comes from the Journal of STEPS for Humanities and Social Sciences, which in 2022 published a piece by a pair of authors in Iraq about trauma fiction.

“Trauma Reverberations: A Study of Selected Novels,” appeared in 2022, and was written by Intisar Rashid Khaleel and Raed Idrees Mahmood, both of Tikrit University.

According to the retraction notice:

Exclusive: NYU cancer center director suspended

The director of one the nation’s premier cancer centers has been suspended amid concerns over several of his papers – but he tells Retraction Watch it is unrelated to comments about that work on PubPeer.

An email Wednesday to employees at New York University’s medical center – and a subsequent message to staff at the institution’s Perlmutter Cancer Center – explained that Benjamin Neel, the former director of the center, had been suspended.

The letter, signed by Steven Abramson, a rheumatologist and executive vice president at NYU Langone Health, did not state the reason for the move:

Paper that helped form basis of pricy research tool retracted

Nearly four years after a critic pointed out flaws in a paper about a controversial research tool involved in nearly 20 retractions, the owner of that instrument has lost the article after he failed to overcome the editors’ concerns about the work.

The owner is Donald Morisky, of the University of California, Los Angeles, whose name should be well-familiar to readers of Retraction Watch.

Morisky developed the Morisky Medication Adherence Scale (MMAS), then began charging researchers up to six-figure sums to license the use of the tool in their own studies. Those who didn’t sign agreements in advance were ordered to retract their papers that used the MMAS, pay Morisky’s company retroactively, or risk legal action. (We wrote about all this in Science back in 2017. We also wrote about how Morisky and his former business partner, Steve Trubow, have been engaged in litigation over ownership of a spin-off “widget” Trubow says belongs to him. That case is ongoing.)

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: